St. Jude Medical received the CE mark for its Ellipse and SJM Assura suite of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The next-generation devices are used to administer high-voltage electricity to heart tissue and come with advanced coating to help lower the risk for electrode lead abrasion.
St. Judes wins CE Mark for next-gen heart defibrillators
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|